US tracker

H.R. 1266

Combating Illicit Xylazine Act

Judiciary Committee, Energy and Commerce Committee · Rep. Jimmy Panetta (D-CA)

15 September 2026 | Passed House with amendment (voice vote)

What's next: To the Senate (if and when it takes it up)

Summary: The bill would regulate xylazine, a veterinary sedative increasingly mixed with fentanyl in illicit drugs, by classifying it as a controlled substance and imposing criminal penalties for illegal manufacturing, distribution, and possession. It would require tracking of xylazine transactions, exempt legitimate veterinary and animal-control uses, and direct the DEA to report on the prevalence and impact of illicit xylazine use in the United States.

[AI-Generated]

Posted 16 September 2026

As published — the exact text this tracker posted, kept verbatim for the record

H.R. 1266 | Combating Illicit Xylazine Act | Rep. Jimmy Panetta (D-CA) | Judiciary Committee, Energy and Commerce Committee 📅 15 September 2026 | ✅🏛️ Passed House with amendment (voice vote) What's next: To the Senate (if and when it takes it up) Summary: The bill would regulate xylazine, a veterinary sedative increasingly mixed with fentanyl in illicit drugs, by classifying it as a controlled substance and imposing criminal penalties for illegal manufacturing, distribution, and possession. It would require tracking of xylazine transactions, exempt legitimate veterinary and animal-control uses, and direct the DEA to report on the prevalence and impact of illicit xylazine use in the United States. [AI-Generated]

Look it up on Congress.gov See the full path of H.R. 1266

A permanent record of a post published by BillTracking's US tracker. The facts are drawn from the official record; the reference above is the lookup key on Congress.gov. Spotted an error? accuracy@billtracking.org.